Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, yet 40% to 50% of patients will eventually succumb to their disease, demonstrating a pressing need for novel therapeutic options. Gene expression profiling has identified messenger RNAs that lead to transformat...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood
Main Authors: Matthews, Julie Marie, Bhatt, Shruti, Patricelli, Matthew P., Nomanbhoy, Tyzoon K., Jiang, Xiaoyu, Natkunam, Yasodha, Gentles, Andrew J., Martinez, Ezequiel, Zhu, Daxing, Chapman, Jennifer Rose, Cortizas, Elena, Shyam, Ragini, Chinichian, Shideh, Advani, Ranjana, Tan, Li, Zhang, Jianming, Choi, Hwan Geun, Tibshirani, Robert, Buhrlage, Sara J., Gratzinger, Dita, Verdun, Ramiro, Gray, Nathanael S., Lossos, Izidore S.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2016
נושאים:
Lymphoid Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946202/
https://ncbi.nlm.nih.gov/pubmed/27151888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-02-696856
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים